Inhibiting Breast Cancer Progression by Exploiting TGF&bgr; Signaling

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|11|9|1089-1102

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.9, 2010-09, pp. : 1089-1102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natural Products and Transforming Growth Factor-beta (TGF-&bgr;) Signaling in Cancer Development and Progression

By  

Current Cancer Drug Targets, Vol. 13, Iss. 5, 2013-06 ,pp. : 500-505

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokines and Invertebrates: TGF-&bgr; and PDGF

By  

Current Pharmaceutical Design, Vol. 12, Iss. 24, 2006-08 ,pp. : 3025-3031

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of the TGF-&bgr; Superfamily and their Clinical Applications

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-11 ,pp. : 1255-1261

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Tolerance and TGF-&bgr; -Producing Cells

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 3, 2006-01 ,pp. : 179-190

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophore and 3D QSAR Study of TGF&bgr; Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 3, 2014-01 ,pp. : 316-330

Bentham Science Publishers

Access to resources Recommend Favorite